Choosing a Heart Hospital in China: Team, Rescue, Quality

Choose a China heart centre by matching the cardiac pathway, verifying the team and 24-hour rescue, comparing treatment alternatives and quality data, and securing implant and follow-up records.

Key takeaways

Pick the centre by the patient’s pathway—acute coronary care, chronic coronary disease, valve/aortic disease, arrhythmia, heart failure, congenital disease, or surgery. A generic “cardiology” label tells you almost nothing.
Ask what happens at 2 a.m. If an elective plan goes wrong in the night, the emergency department, catheter laboratory, cardiac surgery, intensive care, imaging, blood bank, perfusion, and transfer arrangements decide the outcome.
Compare decisions before procedures. With coronary or valve disease, insist on a written explanation of the medical, catheter-based, and surgical alternatives.
Quality claims only mean something with a defined population, denominator, time window, complications, deaths, and follow-up attached. A big case count or an impressive machine is not an outcome.
Before you leave China, collect the implant passport, images, procedure data, medicine plan, warning signs, rehabilitation prescription, and a named home clinician.

Full guide

Most families start by asking which Chinese heart hospital ranks first. The better question is: Which door would this patient need if the condition worsened at 2 a.m., and does the elective team connect to that door?

A cardiology clinic, a catheter laboratory, a cardiac surgical service, an electrophysiology programme, and a transplant centre each solve a different problem. Some hospitals house all of them on one campus; many do not. So choose the pathway first.

First separate emergency care from planned travel

If the patient has new or worsening chest pressure, breathlessness at rest, fainting, a sustained rapid or very slow heartbeat with symptoms, new weakness, shock, or a suspected aortic emergency, skip the travel planning entirely. Use immediate local emergency care. China’s national pre-hospital medical emergency number is 120 [1].

If the patient is stable and travelling for a planned review, write down the decision you need and the deadline: confirm the diagnosis, decide between medicines and revascularisation, compare transcatheter and surgical valve treatment, investigate an arrhythmia, evaluate advanced heart failure, or plan rehabilitation.

Choose one primary pathway

Match the patient’s problem to the programme that handles it:

Patient problem	Core programme	Critical connected services
acute chest pain / myocardial infarction	emergency cardiology and PCI	24-hour lab, cardiac ICU, surgery/transfer, stroke and bleeding response
stable coronary disease	coronary team	physiology/imaging, preventive cardiology, PCI and CABG comparison
valve or aortic disease	structural heart / aortic team	advanced echo/CT, surgery, anaesthesia, perfusion, rescue
rhythm disorder	electrophysiology	ambulatory monitoring, mapping, ablation, devices, anticoagulation, surgery backup
heart failure / cardiomyopathy	heart-failure programme	imaging, haemodynamics, genetics where relevant, devices, ICU, VAD/transplant pathway
congenital heart disease	congenital team	disease-specific imaging, intervention, surgery, lifelong follow-up
postoperative recovery	cardiac rehabilitation	risk stratification, exercise, medicines, nutrition, psychosocial and emergency plan

A famous cardiology department on paper says nothing about whether this particular pathway is mature at this particular campus.

Build a cardiac evidence packet

Send original, dated evidence; a diagnosis label on its own is not enough:

the symptom timeline, plus blood pressure, heart rate, oxygen saturation, weight trend, and exercise tolerance;
the ECGs and rhythm strips themselves, because written interpretations alone are not enough;
echocardiography images and report, including the measurements;
coronary angiography or CT source images when relevant;
cardiac MRI, nuclear imaging, vascular imaging, or catheterisation data where relevant;
laboratory results, including kidney function, blood count, electrolytes, lipids, glucose, coagulation, troponin, and natriuretic peptides as clinically indicated;
reports and operative notes from any previous procedures;
implant manufacturer, model, serial number, date, and latest interrogation;
current medicines, doses, adherence, allergies, and previous intolerance.

Cardiac biomarkers do help with diagnosis and risk assessment, though the results depend on timing and assay context [2]. Ask which studies genuinely need repeating and why. A repeat test should close a decision gap; restarting the whole workup from zero helps no one.

Verify programme, clinician, and campus separately

Verify the legal institution and the practitioner through official health-authority sources first. Then get the hospital to name the current campus, the responsible consultant, the likely operator, the covering team, and the department that owns complications.

Under China’s clinical-application rules, cardiovascular interventional services are managed and evaluated as services, and owning the equipment is the smallest part of that [3]. Past and current requirements both stress institutional capability, appropriately qualified operators, case selection, severe complications, mortality, postoperative management, follow-up, and record quality [4]. Ask for evidence from the present. A credential screenshot or an old training certificate proves very little.

Compare decisions, not devices

With stable coronary disease, have the team weigh guideline-directed medical treatment, PCI, and CABG against the anatomy, symptoms, ischaemia, ventricular function, diabetes, renal function, bleeding risk, frailty, and the patient’s goals. Write down who reviewed the source angiogram, and whether intracoronary physiology or imaging would change the choice.

With valve disease, keep severity, symptoms, and procedural eligibility as three separate questions. Check that a structural cardiologist, a cardiac surgeon, an imaging specialist, and a cardiac anaesthetist all reviewed the case. Then compare transcatheter, surgical, and conservative approaches on durability, anticoagulation, pacemaker risk, coronary access, reintervention, and bailout.

With arrhythmia, pin down the rhythm before anyone talks about ablation. Confirm the monitoring evidence, symptom correlation, structural disease, stroke prevention, expected endpoint, mapping method, sedation, vascular access, and how tamponade, stroke, atrio-oesophageal injury, or device infection would be managed where relevant.

With heart failure, ask for the cause, phenotype, volume status, rhythm, coronary and valve assessment, medicines and tolerated doses, device indications, reversible factors, and trajectory. If a centre brings up transplantation, it should be able to show a stepwise advanced-therapy evaluation. Transplant offered as the first answer is a warning sign.

Ask the 2 a.m. questions

For the exact campus and the exact dates, get answers to:

Is the relevant emergency service open 24 hours?
Can the catheter or electrophysiology laboratory mobilise after hours?
Is cardiac surgery on site, on call, or reached by transfer?
Is there a cardiac ICU with the required monitoring and mechanical support?
Are perfusion, blood bank, vascular surgery, neurology, renal replacement, and advanced imaging available when needed?
Who accepts a deteriorating international patient before records or payment are reconciled?
What is the written transfer pathway if the campus cannot rescue the complication?

Ventricular assist technology and heart transplantation carry their own legal and clinical authorisation, so verify those specifically. The National Health Commission publishes qualified organ-transplant institutions and an official query service [5]. A heart-failure clinic, or a transplant collaboration, does not add up to a licensed heart-transplant programme.

Read quality through the relevant indicator

China’s National Health Commission has published cardiovascular quality-control indicators covering the major disease and procedural pathways [6]. The 2025 national specialty improvement targets even singled out intravascular imaging for left-main PCI, and called for registration of complications, deaths, and follow-up [7].

For the pathway this patient will actually follow, request:

annual eligible cases, both for the site and for the intended operator;
how procedural success is defined;
in-hospital and 30-day death;
the relevant rates of stroke, myocardial infarction, major bleeding, acute kidney injury, vascular complication, infection, reoperation, tamponade, or pacemaker implantation;
conversion or emergency surgery;
readmission and repeat procedures;
how complete follow-up is, and how long it runs;
how risk adjustment and exclusions are handled.

Two percentages are only worth comparing once their patients, definitions, and follow-up match. Also ask how the programme reviews its adverse events and what it changed afterwards.

Make the implant and medicine chain traceable

Any stent, valve, pacemaker, defibrillator, occluder, graft, or assist device should come with its manufacturer, product and model, size, lot/serial or unique identifier, expiry where relevant, implant location, procedure date, operator, and MRI/airport-security conditions. China’s interventional rules require device records to be traceable [4].

The discharge medicine list should give each drug’s generic name, dose, timing, indication, start/stop rules, missed-dose advice, interactions, and who may modify it. Antiplatelet and anticoagulant plans need to be especially clear before dental work, surgery, bleeding, or long travel. If the brand name looks unfamiliar after translation, call the responsible clinician—never simply stop the drug.

Treat cardiac rehabilitation as a prescription

China’s cardiovascular action plan includes secondary prevention and rehabilitation [8]. Ask for an individualised prescription covering exercise intensity, heart-rate or symptom limits, wound and lifting restrictions, blood pressure, nutrition, smoking, sleep, psychological recovery, driving, sexual activity, work, and air travel.

Also confirm the rehabilitation programme’s emergency response and who adjusts the medicines. Gym packages, massage, and resort stays sometimes get sold under this label. Real cardiac rehabilitation is a medical prescription with monitoring behind it.

Price the full pathway

Ask for separate figures covering the review, repeat imaging/labs, the procedure itself, professional fees, anaesthesia, disposables and the implant, ICU, the room, medicines, rehabilitation, interpreter, records, and management of predictable complications. Then clarify deposits, cancellation, product substitution, refunds, and insurer authorisation.

If the plan could switch from catheter treatment to surgery mid-course, get both pathways priced and ask what the financial rule for conversion is. A low procedure quote often leaves out the implant, the imaging guidance, intensive care, or a second intervention.

Close the handoff before flying

Before departure, collect the source ECG, echo, angiography/CT/MRI, haemodynamic and EP data, procedure and operative reports, implant card, medicine reconciliation, kidney and blood results, complications, restrictions, warning signs, rehabilitation plan, and follow-up dates.

For a long journey, ask about timing, mobility, oxygen, venous-thromboembolism risk, wound care, device checks, and access to medicines. A clinician at home should confirm they have received everything and accept responsibility. A centre only earns the booking when both doors are open: the 2 a.m. rescue door and the home-country handoff door.

Medical disclaimer: This guide provides general selection and planning information and does not rank Chinese cardiac institutions or recommend a procedure. Heart symptoms can become emergencies; seek immediate local care for severe or worsening symptoms.

Related guides

Coronary Angiography and PCI in China
CABG in China: Choosing between Surgery and PCI
Valve Repair, Replacement, and Transcatheter Options
Arrhythmia Evaluation and Catheter Ablation
Cardiac Rehabilitation after Treatment

FAQ

Is a dedicated heart hospital always better than a general hospital cardiology centre?

No. What matters is the programme this patient needs and the rescue services connected to it. A general hospital can offer stronger support for complex noncardiac disease, while a heart hospital may run deeper on a specific pathway.

Does a high annual PCI or surgery volume prove better quality?

No. Volume on its own is just context. Compare patient risk, outcomes, complications, rescue, readmissions, and follow-up under the same definitions.

Should a surgeon and interventional cardiologist both review coronary or valve disease?

When the realistic options cross specialties, a documented heart-team comparison lays the trade-offs out on the table and guards against a procedure being chosen only because it happened to be the first service available.

How can I verify a claimed heart-transplant programme?

Check the National Health Commission’s list of qualified organ-transplant institutions, then ask the centre itself to confirm its registered transplant category, current team, evaluation pathway, and follow-up responsibility.

What cardiac records matter most when returning home?

Source imaging and signals, procedure details, haemodynamics, implant identifiers, the medicine plan, complications, restrictions, warning signs, and the next decision point. Those will serve you far better than a short, general discharge letter.

How to Choose a Heart Hospital or Cardiology Centre in China: Start with the 2 a.m. Door